Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yume Nagaoka is active.

Publication


Featured researches published by Yume Nagaoka.


Nephrology | 2012

Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.

Tomonari Okada; Toshitaka Nagao; Hiroshi Matsumoto; Yume Nagaoka; Toshikazu Wada; Toshiyuki Nakao

Aim:  Although several clinical risk factors for end‐stage renal disease in diabetic nephropathy are known, the pathological findings that may help predict renal prognosis have not yet been defined.


Blood Pressure Monitoring | 2012

Association of home blood pressure variability with progression of chronic kidney disease.

Tomonari Okada; Hiroshi Matsumoto; Yume Nagaoka; Toshiyuki Nakao

ObjectiveHome blood pressure (HBP) has been found to be a predictor of the progression of chronic kidney disease (CKD). The objective of this study is to clarify the clinical significance of day-by-day HBP variability on the progression of CKD. MethodsWe recruited 135 patients with stage 3–5 CKD, who performed daily HBP measurements, every morning and evening over 7 consecutive days and recorded every 6 months, with a follow-up of 36 months. We examined the associations between the variables of blood pressure (BP) variability [SD, coefficient of variation (CV), average real variability (ARV)], and renal outcomes. ResultsNo significant correlations were found between the SD values, the CV values, the ARV values of each BP measurement, and the change in estimated glomerular filtration rate on multivariate regression analysis (&bgr; of SD, CV, and ARV of morning systolic BP: 0.04, 0.04, and 0.02; P=0.69, 0.63, and 0.20, respectively). None of these variables of each BP measurement showed a significant risk of renal events on multivariate Cox proportional hazards analysis (hazard ratios of SD, CV, and ARV of morning systolic BP: 0.99 (95% confidence intervals: 0.80–1.23), 0.97 (0.72–1.31), and 1.01 (0.83–1.24); P=0.94, 0.86, and 0.92, respectively). ConclusionDay-by-day BP variability as assessed by HBP measurements had no significant association with the progression of CKD.


Contributions To Nephrology | 2007

Body Protein Index Based on Bioelectrical Impedance Analysis Is a Useful New Marker Assessing Nutritional Status: Applications to Patients with Chronic Renal Failure on Maintenance Dialysis

Toshiyuki Nakao; Yoshie Kanazawa; Yume Nagaoka; Hideaki Iwasawa; Asako Uchinaga; Hiroshi Matsumoto; Tomonari Okada; Maki Yoshino

BACKGROUND Evaluation and monitoring of nutritional status is a fundamental concept in providing nutritional care to patients with end-stage renal failure. There have been, however, few practically available indices assessing whole body protein stores of patients. METHODS We enrolled 448 end-stage renal disease patients, 394 on maintenance hemodialysis (HD) and 54 on continuous ambulatory peritoneal dialysis (PD) in this study. 83 Age- and sex-matched subjects (controls) whose creatinine clearance was more than 70 ml/min and urinary protein excretion was less than 1.0 g/day were also recruited for comparison. To assess whole body somatic protein stores, we devised the body protein index (BPI). The volume of body protein mass was measured by multifrequency bioelectrical impedance analysis and then BPI was calculated as body protein mass (kg) divided by height in meters (m2). Based on BPI, we defined the nutritional status of the patients as normal if the value was within -10% of the mean value of control subjects, -10 to -14% as mild malnutrition, -15 to -19% as moderate malnutrition, and <-20% as severe malnutrition. RESULTS The required time for measurement was 5.2 +/- 1.3 min and coefficient of variation of measurements was 0.8 +/- 0.2%. Among men the mean BPI in both HD and PD patients was significantly lower than those of control subjects (4.25 +/- 0.37, 4.38 +/- 0.34 vs. 4.72 +/- 0.37 kg/m2, p < 0.001). In women, BPI was significantly lower in HD patients than in control subjects (3.65 +/- 0.34 vs. 4.00 +/- 0.34 kg/m2, p < 0.033), whereas only a nonsignificant lower tendency was found in PD patients (3.83 +/- 0.39 kg/m2, p = 0.067). There were no significant differences in BPI values between diabetic and non-diabetic subjects, both in men (4.26 +/- 0.41 vs. 4.25 +/- 0.36 kg/m2) and women (3.69 +/- 0.36 vs. 3.65 +/- 0.34 kg/m2). Based on BPI nutritional categories, 113 (28.7%) of all HD patients were classified as having mild malnutrition, 57 (14.5%) as having moderate malnutrition, 40 (10.1%) as having severe malnutrition, and 184 (46.7%) were classified as normal. The patients of longer dialysis history groups showed a tendency of lower BPI compared to those of shorter dialysis history groups (p < 0.05), although the ages of the patients of the two groups did not significantly differ. No correlations were found between BPI and serum albumin or transferrin concentrations. Only weak correlations were found with albumin in male and transferrin in female HD patients. CONCLUSION BPI calculated from measurement of multifrequency bioelectrical impedance analysis could evaluate whole body somatic protein stores, and is a potentially useful new marker assessing nutritional status in patients with chronic renal failure. Decreased body somatic protein stores, mainly due to muscle wasting, was prevalent in end-stage renal failure patients on maintenance dialysis.


Hypertension Research | 2009

Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Yume Nagaoka; Ryo Tomaru; Hideaki Iwasawa; Toshikazu Wada

The influence of home blood pressure (HBP) control on renal and cardiovascular outcomes is not fully defined, and the optimal blood pressure (BP) target in elderly patients with chronic kidney disease (CKD) remains unknown. To clarify the influence of HBP on the progression of CKD and the occurrence of cardiovascular events in elderly CKD patients, we recruited 104 patients with stage 3 to 5 CKD, who were ⩾70 years of age. The mean follow-up duration was 39±15 months. HBP was measured every morning and evening for 7 consecutive days. HBP data were obtained every 6 months for 79 of these patients. There were significant correlations observed between morning systolic BP (SBP), evening SBP and the change in estimated glomerular filtration rate (eGFR) during the follow-up period (baseline/follow-up; morning r=−0.55/−0.51, evening r=−0.48/−0.38, all P<0.0001, baseline: baseline values, follow-up: mean values obtained every 6 months during the follow-up period). Stepwise multivariate regression analysis identified morning SBP and urinary protein excretion as independent predictors of a change in eGFR during the follow-up period. Cox proportional hazards analysis showed that baseline morning SBP, baseline evening SBP and follow-up morning SBP were significantly associated with an increased risk of renal events (hazard ratios; 1.04 (95% CI, 1.01–1.07), 1.06 (1.02–1.09) and 1.10 (1.04–1.17), respectively). However, Cox proportional hazards analyses showed that there was no significant association between BP and the risk of cardiovascular events. In conclusion, even among elderly CKD patients, HBP is a significant predictor of decline in renal function and the development of end-stage renal disease. In addition, the optimal target BP for elderly CKD patients needs to be clarified.


Nephrology | 2013

Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.

Tomonari Okada; Toshitaka Nagao; Hiroshi Matsumoto; Yume Nagaoka; Toshikazu Wada; Toshiyuki Nakao

Although some patients with diabetic nephropathy with overt proteinuria have microscopic haematuria, the pathological characteristics and clinical significance related to microscopic haematuria have not yet been clarified. The aim of the present study was to clarify the pathological characteristics and clinical significance of microscopic haematuria.


Nephrology | 2002

Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Hirgmi Hidaka; Maki Yoshino; Tamami Shino; Yume Nagaoka; Humihiro Takeguchi; Hideaki Iwasawa; Ryo Tomaru

SUMMARY: We investigated to clarify the predialysis factors associated with prognosis in type 2 diabetic patients entering chronic dialysis. One hundred and twenty‐four type 2 diabetic patients who started chronic dialysis in our department between January 1992 and November 2000 were studied. the variables in the predialysis period and those at initiation of dialysis were collected and evaluated in association with prognosis after a mean follow up of 37 ± 23 months from initiation of dialysis by using Coxs proportional‐hazards model. the 1‐, 3‐, and 5‐year survival rates after initiating chronic dialysis were 92.7, 74.6, and 56.5%, respectively. During follow up, 40 patients died. Univariate analysis demonstrated that serum albumin (Alb) levels, haemoglobin A1c, and no preparation for permanent vascular or peritoneal access at initiation of dialysis were significantly associated with prognosis. In multivariate analysis, Alb levels (hazard ratio, 2.09, per decrease of 1 g/dL; confidence interval, 1.05–4.19), and age (1.54, per decrease of 10 years; 1.06–2.22) at initiation of dialysis remained significant predictors of mortality. In conclusion, Alb levels and age at initiation of dialysis are associated with prognosis in type 2 diabetic patients on chronic dialysis. It should be elucidated whether improvement of Alb levels at initiation of dialysis would have a favourable influence on survival after diabetic patients with renal failure are entered into chronic dialysis.


American Journal of Nephrology | 2008

Value of Morning Home Blood Pressure as a Predictor of Decline in Renal Function in Patients with Chronic Kidney Disease

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Yume Nagaoka

BACKGROUND Although blood pressure (BP) control is significantly associated with progression of chronic kidney disease (CKD), the influence of BP control based on home BP (HBP) measurement on the change in renal function in CKD patients is not fully defined. METHODS We recruited 137 patients with stage 3-5 CKD, who performed daily HBP measurements continuously. HBP was measured every morning and evening and data were obtained every 6 months in each patient with a follow-up of 32 +/- 5 months. The associations between BP data, other clinical variables and the change in estimated glomerular filtration rate (eGFR) were examined. RESULTS Mean morning BP, evening BP and clinic BP were 132.9/76.2, 128.5/72.5 and 129.4/69.1 mm Hg, respectively. There were significant correlations between mean morning systolic BP (SBP), mean evening SBP, mean clinic SBP and the change in eGFR (r = -0.318, -0.215, -0.174, p < 0.0001, <0.05, <0.05). Stepwise multivariate regression analysis demonstrated mean morning SBP and mean urinary protein excretion as independent predictors of the change in eGFR. CONCLUSION Morning SBP is a more significant predictor of decline in renal function than evening SBP or clinic SBP.


Nephrology | 2013

Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis.

Hideaki Iwasawa; Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Yume Nagaoka; Toshikazu Wada

We investigated the handling of phosphate by end‐stage kidneys and the contribution of residual renal function (RRF) to phosphate homeostasis in haemodialysis patients.


Nephrology | 2011

Clinical evaluation of chronic nephrotoxicity of long-term cyclosporine A treatment in adult patients with steroid-dependent nephrotic syndrome

Tomonari Okada; Hiroshi Matsumoto; Yume Nagaoka; Ryo Tomaru; Hideaki Iwasawa; Toshikazu Wada; Toshiyuki Nakao

Aim:  Chronic nephrotoxicity of long‐term cyclosporine A (CsA) treatment is a matter of concern in patients with steroid‐dependent nephrotic syndrome (SDNS).


Nephrology | 2011

Benefits of first-half intensive haemodiafiltration for the removal of uraemic solutes

Yume Nagaoka; Hiroshi Matsumoto; Tomonari Okada; Hideaki Iwasawa; Ryo Tomaru; Toshikazu Wada; Asako Gondo; Toshiyuki Nakao

Aim:  Haemodiafiltration (HDF) is the most efficient blood purification method and can remove a wide spectrum of solutes of different molecular weights (MW). The purpose of this study was to investigate whether the removed amounts of solutes, especially the larger molecules, could be increased by changing the HDF filtration procedure.

Collaboration


Dive into the Yume Nagaoka's collaboration.

Top Co-Authors

Avatar

Tomonari Okada

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Matsumoto

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshikazu Wada

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Maki Yoshino

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryo Tomaru

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiromi Hidaka

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Tamami Shino

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Asako Gondo

Tokyo Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge